UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort

Lupus science & medicine, 2022-08, Vol.9 (1), p.e000598

2022

Volltextzugriff (PDF)

1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A70-A71

2022

Volltextzugriff (PDF)

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

Human vaccines & immunotherapeutics, 2012-08, Vol.8 (8), p.1119-1125

2012

Volltextzugriff (PDF)

Clinical Outcomes in Lupus Nephritis by Renal Response Status: A Retrospective Analysis of the Hopkins Lupus Cohort: PO1919

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.595-595

2020

Volltextzugriff (PDF)

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

The Journal of infectious diseases, 2016-12, Vol.214 (11), p.1717-1727

2016

Volltextzugriff (PDF)

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study

Clinical journal of the American Society of Nephrology, 2022-11, Vol.17 (11), p.1620-1630

2022

Volltextzugriff (PDF)

Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population

American journal of kidney diseases, 2023-03, Vol.81 (3), p.294-306.e1

2023

Volltextzugriff (PDF)

FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Volltextzugriff (PDF)

Bidirectional Transport of Glucocorticoid Receptors Across the Nuclear Envelope

Proceedings of the National Academy of Sciences - PNAS, 1993-04, Vol.90 (8), p.3588-3592

1993

Volltextzugriff (PDF)

Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN): SA-OR32

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.48-49

2021

Volltextzugriff (PDF)

Belimumab (BEL) Improves Renal Outcomes in Active Lupus Nephritis (LN): A Phase 3 Randomized, Placebo (PBO)-Controlled Trial: SU-OR34

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.54-54

2020

Volltextzugriff (PDF)

Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial

Vaccine, 2017-08, Vol.35 (35), p.4621-4628

2017

Volltextzugriff (PDF)

Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial

Journal of the American Society of Hypertension, 2009-05, Vol.3 (3), p.210-220

2009

Volltextzugriff (PDF)

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial

Vaccine, 2017-03, Vol.35 (10), p.1431-1439

2017

Volltextzugriff (PDF)

LB001EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PHASE 3, RANDOMISED, PLACEBO-CONTROLLED TRIAL

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Rapid immunization against H5N1: a randomized trial evaluating homologous and cross-reactive immune responses to AS03(A)-adjuvanted vaccination in adults

The Journal of infectious diseases, 2011-08, Vol.204 (4), p.574-581

2011

Volltextzugriff (PDF)

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial

Vaccine, 2017-04, Vol.35 (15), p.1865-1872

2017

Volltextzugriff (PDF)

Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Open forum infectious diseases, 2019-04, Vol.6 (4), p.ofz163-ofz163

2019

Volltextzugriff (PDF)

Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03A- Adjuvanted Vaccination in Adults

The Journal of infectious diseases, 2011-08, Vol.204 (4), p.574-581

2011

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza

Open forum infectious diseases, 2019-04, Vol.6 (4), p.ofz072-ofz072

2019

Volltextzugriff (PDF)

Evaluation of immune response following one dose of an AS03 A -adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

Human vaccines & immunotherapeutics, 2012-08, Vol.8 (8), p.1119-1125

2012

Volltextzugriff (PDF)

Efficacy and Safety of Danirixin : A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Open forum infectious diseases, 2019-04, Vol.6 (4)

2019

Volltextzugriff (PDF)

Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03 sub(A)-Adjuvanted Vaccination in Adults

The Journal of infectious diseases, 2011-08, Vol.204 (4), p.574-581

2011

Volltextzugriff (PDF)

Epigenetic regulation of maspin expression in the human placenta

Molecular human reproduction, 2006-10, Vol.12 (10), p.611-617

2006

Volltextzugriff (PDF)

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

BMC infectious diseases, 2013-09, Vol.13 (1), p.435-435, Article 435

2013

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(23)
Humans
(19)
Female
(11)
Adult
(10)
Influenza
(9)
Male
(9)
Infectious Diseases
(7)
Microbiology
(7)
Adults
(6)
Biological And Medical Sciences
(6)
Immunology
(6)
Influenza Vaccines - Immunology
(6)
Fundamental And Applied Biological Sciences. Psychology
(5)
Influenza Vaccines - Administration & Dosage
(5)
Influenza, Human - Prevention & Control
(5)
Middle Aged
(5)
Pandemic
(5)
Pandemics
(5)
Proteins
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort

1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN)

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

Clinical Outcomes in Lupus Nephritis by Renal Response Status: A Retrospective Analysis of the Hopkins Lupus Cohort: PO1919

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study

Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population

FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION

Bidirectional Transport of Glucocorticoid Receptors Across the Nuclear Envelope

Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN): SA-OR32

Belimumab (BEL) Improves Renal Outcomes in Active Lupus Nephritis (LN): A Phase 3 Randomized, Placebo (PBO)-Controlled Trial: SU-OR34

Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial

Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial

LB001EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PHASE 3, RANDOMISED, PLACEBO-CONTROLLED TRIAL

Rapid immunization against H5N1: a randomized trial evaluating homologous and cross-reactive immune responses to AS03(A)-adjuvanted vaccination in adults

Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65years of age and older: A phase II, observer-blind, randomized, controlled trial

Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03A- Adjuvanted Vaccination in Adults

Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza

Evaluation of immune response following one dose of an AS03 A -adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older

Efficacy and Safety of Danirixin : A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03 sub(A)-Adjuvanted Vaccination in Adults

Epigenetic regulation of maspin expression in the human placenta

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials

Suchergebnisse filtern